Advertisement

Penile Ultrasound

  • Soroush Rais-Bahrami
  • Bruce R. GilbertEmail author
Chapter
Part of the Current Clinical Urology book series (CCU)

Abstract

Penile ultrasound is commonly used in the diagnostic workup of a patient with erectile dysfunction (ED) but also plays an important role by providing an anatomic and functional vascular assessment in a multitude of other conditions including Peyronie’s disease, high-flow priapism, penile fracture, penile urethral strictures, urethral stones, or diverticulae, or masses involving deep tissues of the penis. As a component of the evaluation for ED, penile Doppler ultrasound (PDU) is performed to assess the quality of arterial blood flow and sufficiency of veno-occlusive mechanisms, both necessary for an adequate erection. More recently, this imaging modality is playing a central role in the early detection and diagnosis of otherwise silent coronary artery disease (CAD) in men who present with ED as their initial symptom. PDU is also an essential component of the assessment of external genitalia in trauma situations where high-flow priapism or penile fracture is suspected. Penile ultrasound provides a readily available, minimally invasive diagnostic modality that evaluates both the structural anatomy and functional hemodynamics at a reasonable cost.

Keywords

Erectile Dysfunction Peak Systolic Flow Velocity Urethral Stricture Tunica Albuginea Penile Shaft 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Doubilet PM, Benson CB, Silverman SG, et al. The penis. Semin Ultrasound CT MR. 1991;12:157.PubMedGoogle Scholar
  2. 2.
  3. 3.
    Shin D, Pregenzer Jr G, Gardin JM. Erectile dysfunction: a disease marker for cardiovascular disease. Cardiol Rev. 2011;19:5.PubMedCrossRefGoogle Scholar
  4. 4.
    Tomada N, Tomada I, Botelho F, et al. Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment. J Sex Med. 2011;8(3):831–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Corona G, Monami M, Boddi V, et al. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med. 2010; 7:1918.PubMedCrossRefGoogle Scholar
  6. 6.
    Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170: 1566.PubMedCrossRefGoogle Scholar
  7. 7.
    Hayashi T, Farrell MA, Chaput LA, et al. Lifestyle intervention, behavioral changes, and improvement in cardiovascular risk profiles in the California WISEWOMAN project. J Womens Health (Larchmt). 2010;19:1129.CrossRefGoogle Scholar
  8. 8.
    Miner MM. Erectile dysfunction: a harbinger or consequence: does its detection lead to a window of curability? J Androl. 2011;32:125.PubMedCrossRefGoogle Scholar
  9. 9.
    Inman BA, Sauver JL, Jacobson DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84:108.PubMedCrossRefGoogle Scholar
  10. 10.
    Billups KL, Bank AJ, Padma-Nathan H, et al. Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res. 2008;20:236.PubMedCrossRefGoogle Scholar
  11. 11.
    Patel U, Lees WR. Penile sonography. In: Solibiati L, Rizzatto G, editors. Ultrasound of superficial structures. London: Churchill Livingstone; 1995. p. 229–42.Google Scholar
  12. 12.
    Wilkins CJ, Sriprasad S, Sidhu PS. Colour Doppler ultrasound of the penis. Clin Radiol. 2003;58:514.PubMedCrossRefGoogle Scholar
  13. 13.
    Kim SH, Paick JS, Lee SE, et al. Doppler sonography of deep cavernosal artery of the penis: variation of peak systolic velocity according to sampling location. J Ultrasound Med. 1994;13:591.PubMedGoogle Scholar
  14. 14.
    Roy C, Saussine C, Tuchmann C, et al. Duplex Doppler sonography of the flaccid penis: potential role in the evaluation of impotence. J Clin Ultrasound. 2000;28:290.PubMedCrossRefGoogle Scholar
  15. 15.
    Mancini M, Bartolini M, Maggi M, et al. Duplex ultrasound evaluation of cavernosal peak systolic velocity and waveform acceleration in the penile flaccid state: clinical significance in the assessment of the arterial supply in patients with erectile dysfunction. Int J Androl. 2000;23:199.PubMedCrossRefGoogle Scholar
  16. 16.
    van Ahlen H, Peskar BA, Sticht G, et al. Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum. J Urol. 1994;151:1227.PubMedGoogle Scholar
  17. 17.
    Patel U, Amin Z, Friedman E, et al. Colour flow and spectral Doppler imaging after papaverine-induced penile erection in 220 impotent men: study of temporal patterns and the importance of repeated sampling, velocity asymmetry and vascular anomalies. Clin Radiol. 1993;48:18.PubMedCrossRefGoogle Scholar
  18. 18.
    Broderick GA, Lue TF. The penile blood flow study: evaluation of vasculogenic impotence. In: Jonas U, Thon WF, Stief CG, editors. Erectile dysfunction. Berlin: Springer; 1991.Google Scholar
  19. 19.
    Shabsigh R, Fishman IJ, Shotland Y, et al. Comparison of penile duplex ultrasonography with nocturnal penile tumescence monitoring for the evaluation of erectile impotence. J Urol. 1990;143:924.PubMedGoogle Scholar
  20. 20.
    Benson CB, Vickers MA. Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol. 1989;153:1149.PubMedCrossRefGoogle Scholar
  21. 21.
    Lue TF, Hricak H, Marich KW, et al. Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology. 1985;155:777.PubMedGoogle Scholar
  22. 22.
    Mueller SC, Lue TF. Evaluation of vasculogenic impotence. Urol Clin North Am. 1988;15:65.PubMedGoogle Scholar
  23. 23.
    Pescatori ES, Hatzichristou DG, Namburi S, et al. A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study. J Urol. 1994;151:1209.PubMedGoogle Scholar
  24. 24.
    Benson CB, Aruny JE, Vickers Jr MA. Correlation of duplex sonography with arteriography in patients with erectile dysfunction. AJR Am J Roentgenol. 1993; 160:71.PubMedCrossRefGoogle Scholar
  25. 25.
    Bassiouny HS, Levine LA. Penile duplex sonography in the diagnosis of venogenic impotence. J Vasc Surg. 1991;13:75.PubMedCrossRefGoogle Scholar
  26. 26.
    Quam JP, King BF, James EM, et al. Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol. 1989;153:1141.PubMedCrossRefGoogle Scholar
  27. 27.
    Naroda T, Yamanaka M, Matsushita K, et al. [Clinical studies for venogenic impotence with color Doppler ultrasonography–evaluation of resistance index of the cavernous artery]. Nippon Hinyokika Gakkai Zasshi. 1996;87:1231.PubMedGoogle Scholar
  28. 28.
    Cormio L, Bettocchi C, Ricapito V, et al. Resistance index as a prognostic factor for prolonged erection after penile dynamic colour Doppler ultrasonography. Eur Urol. 1998;33:94.PubMedCrossRefGoogle Scholar
  29. 29.
    Feldman HA, Johannes CB, Derby CA, et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000;30:328.PubMedCrossRefGoogle Scholar
  30. 30.
    Blumentals WA, Gomez-Caminero A, Joo S, et al. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res. 2004;16:350.PubMedCrossRefGoogle Scholar
  31. 31.
    Sullivan ME, Thompson CS, Dashwood MR, et al. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43:658.PubMedCrossRefGoogle Scholar
  32. 32.
    Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003;89:251.PubMedCrossRefGoogle Scholar
  33. 33.
    Montorsi P, Montorsi F, Schulman CC. Is erectile dysfunction the “tip of the iceberg” of a systemic vascular disorder? Eur Urol. 2003;44:352.PubMedCrossRefGoogle Scholar
  34. 34.
    Guay AT. The emerging link between hypogonadism and metabolic syndrome. J Androl. 2009;30:370.PubMedCrossRefGoogle Scholar
  35. 35.
    Traish AM, Guay AT. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med. 2006;3:382.PubMedCrossRefGoogle Scholar
  36. 36.
    Lue TF, Tanagho EA. Physiology of erection and pharmacological management of impotence. J Urol. 1987;137:829.PubMedGoogle Scholar
  37. 37.
    O’Kane PD, Jackson G. Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract. 2001;55:219.PubMedGoogle Scholar
  38. 38.
    Mulhall J, Teloken P, Barnas J. Vasculogenic erectile dysfunction is a predictor of abnormal stress echocardiography. J Sex Med. 2009;6:820.PubMedCrossRefGoogle Scholar
  39. 39.
    Zambon JP, Mendonca RR, Wroclawski ML, et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: case–control study. Sao Paulo Med J. 2010;128:137.PubMedCrossRefGoogle Scholar
  40. 40.
    Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56:1113.PubMedCrossRefGoogle Scholar
  41. 41.
    Bohm M, Baumhakel M, Teo K, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 2010;121:1439.PubMedCrossRefGoogle Scholar
  42. 42.
    Batty GD, Li Q, Czernichow S, et al. Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. J Am Coll Cardiol. 2010;56:1908.PubMedCrossRefGoogle Scholar
  43. 43.
    Kang BC, Lee DY, Byun JY, et al. Post-traumatic arterial priapism: colour Doppler examination and ­superselective arterial embolization. Clin Radiol. 1998; 53:830.PubMedCrossRefGoogle Scholar
  44. 44.
    Asgari MA, Hosseini SY, Safarinejad MR, et al. Penile fractures: evaluation, therapeutic approaches and long-term results. J Urol. 1996;155:148.PubMedCrossRefGoogle Scholar
  45. 45.
    El-Bahnasawy MS, Gomha MA. Penile fractures: the successful outcome of immediate surgical intervention. Int J Impot Res. 2000;12:273.PubMedCrossRefGoogle Scholar
  46. 46.
    Atan A, Gungor S, Ozergin O, et al. Idiopathic penile mondors’ disease: a case report. Int Urol Nephrol. 2002;34:97.PubMedCrossRefGoogle Scholar
  47. 47.
    Dicuio M, Pomara G, Ales V, et al. Doppler ultrasonography in a young patient with penile Mondor’s disease. Arch Ital Urol Androl. 2005;77:58.PubMedGoogle Scholar
  48. 48.
    Sasso F, Gulino G, Basar M, et al. Penile Mondors’ disease: an underestimated pathology. Br J Urol. 1996;77:729.PubMedCrossRefGoogle Scholar
  49. 49.
    Nachmann MM, Jaffe JS, Ginsberg PC, et al. Sickle cell episode manifesting as superficial thrombophlebitis of the penis. J Am Osteopath Assoc. 2003; 103:102.PubMedGoogle Scholar
  50. 50.
    Luzzi GA, Pattinson J, Wathen CG. Penile Mondor’s disease and inherited thrombophilia. Int J STD AIDS. 2006;17:70.PubMedCrossRefGoogle Scholar
  51. 51.
    Brock G, Hsu GL, Nunes L, et al. The anatomy of the tunica albuginea in the normal penis and Peyronie’s disease. J Urol. 1997;157:276.PubMedCrossRefGoogle Scholar
  52. 52.
    Chou YH, Tiu CM, Pan HB, et al. High-resolution real-time ultrasound in Peyronie’s disease. J Ultrasound Med. 1987;6:67.PubMedGoogle Scholar
  53. 53.
    Kadioglu A, Tefekli A, Erol H, et al. Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res. 2000;12:263.PubMedCrossRefGoogle Scholar
  54. 54.
    Horenblas S, Kroger R, Gallee MP, et al. Ultrasound in squamous cell carcinoma of the penis; a useful addition to clinical staging? A comparison of ultrasound with histopathology. Urology. 1994;43:702.PubMedCrossRefGoogle Scholar
  55. 55.
    Lont AP, Besnard AP, Gallee MP, et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU Int. 2003;91:493.PubMedCrossRefGoogle Scholar
  56. 56.
    Lan SK, Lin CW, Ho HC, et al. Penile metastasis ­secondary to nasal NK/T-cell lymphoma. Urology. 2008;72:1014.PubMedCrossRefGoogle Scholar
  57. 57.
    Gallentine ML, Morey AF. Imaging of the male ­urethra for stricture disease. Urol Clin North Am. 2002;29:361.PubMedCrossRefGoogle Scholar
  58. 58.
    Morey AF, McAninch JW. Role of preoperative ­sonourethrography in bulbar urethral reconstruction. J Urol. 1997;158:1376.PubMedCrossRefGoogle Scholar
  59. 59.
    Choudhary S, Singh P, Sundar E, et al. A comparison of sonourethrography and retrograde urethrography in evaluation of anterior urethral strictures. Clin Radiol. 2004;59:736.PubMedCrossRefGoogle Scholar
  60. 60.
    Morey AF, McAninch JW. Sonographic staging of anterior urethral strictures. J Urol. 2000;163:1070.PubMedCrossRefGoogle Scholar
  61. 61.
    Kim B, Kawashima A, LeRoy AJ. Imaging of the male urethra. Semin Ultrasound CT MR. 2007; 28:258.PubMedCrossRefGoogle Scholar
  62. 62.
    Bearcroft PW, Berman LH. Sonography in the ­evaluation of the male anterior urethra. Clin Radiol. 1994; 49:621.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Hofstra North Shore LIJ School of MedicineThe Arthur Smith Institute for UrologyNew Hyde ParkUSA
  2. 2.Hofstra North Shore LIJ School of MedicineThe Arthur Smith Institute for UrologyNew Hyde ParkUSA

Personalised recommendations